WELLESLEY HILLS, Mass. -- Point Therapeutics today announced that it has received proxies sufficient to approve the pending merger transaction with DARA BioSciences, Inc. and certain matters related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback